MACRA Compliance: The Financial Impact on Dermatology Practices
The Medicare Access and CHIP Reauthorization Act (MACRA) went into effect January 1, 2017. Under this program, physicians can either earn a bonus or be penalized via reduced reimbursement.
Learn more about how MACRA can impact your practice’s bottom line:
- The difference between the minimum and maximum reimbursement rates can add up to more than a $1M over just a few years.
- In the first year under MACRA, QualDerm-affiliated practices are on track to capitalize on reimbursement bonuses that CMS has ear-marked for exceptional performers.
- MACRA-required quality data can be leveraged during payer contract negotiations – QualDerm used this data to increase reimbursement rates with the market’s largest payer by 7%.